CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −2,248 | $263.58 | $593K | 1,415,707 |
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −4,852 | $264.64 | $1.3M | 1,410,855 |
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −6,000 | $265.16 | $1.6M | 1,404,855 |
| 2026-03-04 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,700 | $266.42 | $453K | 1,403,155 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −483 | $257.31 | $124K | 1,499,770 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −470 | $258.38 | $121K | 1,499,300 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −1,377 | $259.87 | $358K | 1,497,923 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −3,128 | $260.49 | $815K | 1,494,795 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,962 | $261.41 | $774K | 1,491,833 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,380 | $262.44 | $625K | 1,489,453 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,043 | $263.70 | $539K | 1,487,410 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −8,798 | $264.85 | $2.3M | 1,478,612 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −2,439 | $265.59 | $648K | 1,476,173 |
| 2026-03-04 | Krishnan Krish S President and CEO | Sale 10b5-1 | −920 | $266.56 | $245K | 1,475,253 |
| 2026-03-02 | ROMANO KATHRYN Chief Accounting Officer | Sale 10b5-1 | −750 | $267.60 | $201K | 22,366 |
| 2026-02-27 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +7,500 | 26,068 | ||
| 2026-02-27 | ROMANO KATHRYN Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −3,262 | $275.64 | $899K | 22,806 |
| 2026-02-27 | ROMANO KATHRYN Chief Accounting Officer | Option exercise 10b5-1 | +550 | 23,356 | ||
| 2026-02-27 | ROMANO KATHRYN Chief Accounting Officer | Shares withheld for taxes 10b5-1 | −240 | $275.64 | $66K | 23,116 |
| 2026-02-27 | ROMANO KATHRYN Chief Accounting Officer | Option exercise · Performance Stock Units 10b5-1 | −7,500 | 0 |
Page 5 of 35 · 689 trades